Clinical trial
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
NCT00378066 · Asan Medical Center, Other · Completed
Key facts
| NCT number | NCT00378066 |
|---|---|
| Title | Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer |
| Official title | A Phase II Study of Combination Chemotherapy With Bevacizumab, Capecitabine and Oxaliplatin in Patients With Previously Untreated Metastatic or Recurrent Colorectal Cancer |
| Lead sponsor | Asan Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Bevacizumab |
| Enrollment | 49 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Sep 19, 2006 |
| Last update posted | Jan 23, 2013 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: